Traiki TAB, et al. – This study aimed at analyzing the outcomes of patients developing pulmonary metastases (PM) following cytoreductive surgery (CRS) and perioperative intra–peritoneal chemotherapy (IPC) for colorectal cancer (CRC) with peritoneal carcinomatosis. Authors recognized PM development in approximately a fourth of patients undergoing CRS/IPC for CRC. Of these, about 1/3 seemed eligible for percutaneous lung ablative therapy (PLAT). PLAT proved a valuable treatment option providing good local control and potentially prolongation of overall survival.